Skip to content

A Telephone Feedback System for Prevention of Chronic Pain Relapse

CompletedNot applicableNCT00266773
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to determine whether a telephone-based self-monitoring and skills review program with personalized therapist feedback following group CST for chronic pain can reduce and prevent relapse of the pain, physical disability, and psychological distress experienced by patients with chronic pain of the muscles and bone.

Study details

Official title
Therapeutic Interactive Voice Response (IVR) for Relapse Prevention in Chronic Pain
Conditions
  • Chronic Pain and Relapse Prevention
Interventions
  • Behavioral: Chronic pain therapeutic interactive voice response (TIVR) system
Sponsor
University of Vermont
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Vermont Medical Center
Start date
2005-11
Primary completion
2012-01
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Completed 11 weeks of CST through the University of Vermont College of Medicine - Health Behavior Research Center prior to study entry * At least 6 months of musculoskeletal pain caused by back, neck, or shoulder pain; osteoarthritis; or fibromyalgia * Meet study threshold for pain severity with a Typical Pain score of 4 or more on a 10-point scale adapted from the McGill Pain Questionnaire (80) * Receiving ongoing standard pain management from a physician (typically involving oral analgesic medication and physical therapy, with or without anesthetic or steroid injections) Exclusion Criteria: * Unable to perform usual self care * Cancer that causes or influences patient's chronic pain * Cancer requiring radiation or chemotherapy or metastatic cancer of any type * Reflex sympathetic dystrophy (RSD) * Neuropathic pain * Awaiting a pain-related surgical procedure * Involved in pain-related litigation or awaiting disability determination * Behavioral problems or psychotic disorders that may interfere with the study * Inability to use telephone-based TIVR due to cognitive or hearing impairment * At risk for suicide

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00266773